Over the past 12 months, 1 insider at Seaport Therapeutics, Inc. filed 1 open-market SEC Form 4 transaction on SPTX: 1 purchase worth $19.8M and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on May 4, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 4, 26 | Arch Venture Partners Xii, Llc | BUY | 1.10M | $18.00 | $19.8M |
Over the past 12 months, insiders at Seaport Therapeutics, Inc. filed 1 open-market purchase worth $19.8M and 0 sales worth $0 on SPTX, which makes them net buyers over the period. The most recent Form 4 was filed on May 4, 26.
The largest recent open-market SPTX insider purchase in our data was $19.8M by Arch Venture Partners Xii, Llc, filed on May 4, 26.
1 different insider at Seaport Therapeutics, Inc. filed open-market SEC Form 4 transactions on SPTX over the last 12 months.
InsiderTape plots every SPTX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Seaport Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →